In contrast to patients with AKR1D1 deficiency, Akr1d1–/– mice did not show overt signs of cholestasis (Supplementary Fig. 2A), hepatic inflammation (Supplementary Fig. 2B) or liver damage (Supplementary Fig. 2C and D). Here, AKR1D1 is linked to cholestasis.